Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
Eligibility Criteria
- * Study participants ≥ 1 month of age with a confirmed diagnosis of epilepsy who participated in core study N01266 \[NCT01364597\] and/or N01349 \[NCT03325439\]
- * Study participant is ≥ 4 years to \< 16 years of age
- * Study participant has presence of an electroencephalogram (EEG) reading compatible with the diagnosis of focal epilepsy within the last 10 years
- * Study participant has uncontrolled partial-onset seizure (POS) after an adequate course of treatment with at least 1 antiepileptic drug (AED)
- * Study participant had at least 1 POS during the 4-week Screening Period
- * Severe medical, neurological, or psychiatric disorders or laboratory values, which may have an impact on the safety of the study participant
- * Study participant is currently participating in another study of an investigational medication (or a medical device) other than brivaracetam (BRV).
- * Study participant has a history of primary generalized epilepsy, psychogenic non-epileptic seizures, or febrile seizures
- * Study participant has a history of status epilepticus in the 30 days prior to the Screening Visit (ScrV) or during the Screening Period
- * Study participant has any clinically significant illness
- * Study participant has clinically significant laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results
- * Study participant has a clinically significant ECG abnormality
- * Study participant had major surgery within 6 months prior to the ScrV
Ages Eligible for Study
1 Month to
Sexes Eligible for Study
ALL
Accepts Healthy Volunteers
No